More and more research works have indicated that microRNAs (miRNAs) play indispensable roles in exploring the pathogenesis of diseases. Detecting miRNA-disease associations by experimental techniques in biology is expensive and time-consuming. Hence, it is important to propose reliable and accurate computational methods to exploring potential miRNAs related diseases. In our work, we develop a novel method (BRWHNHA) to uncover potential miRNAs associated with diseases based on hybrid recommendation algorithm and unbalanced bi-random walk. We first integrate the Gaussian interaction profile kernel similarity into the miRNA functional similarity network and the disease semantic similarity network. then we calculate the transition probability matrix of bipartite network by using hybrid recommendation algorithm. Finally, we adopt unbalanced bi-random walk on the heterogeneous network to infer undiscovered miRNA-disease relationships. We tested BRWHNHA on 22 diseases based on five-fold cross-validation and achieves reliable performance with average AUC of 0.857, which an area under the ROC curve ranging from 0.807 to 0.924. As a result, BRWHNHA significantly improves the performance of inferring potential miRNA-disease association compared with previous methods. Moreover, the case studies on lung neoplasms and prostate neoplasms also illustrate that BRWHNHA is superior to previous prediction methods and is more advantageous in exploring potential miRNAs related diseases. All source codes can be downloaded from https://github.com/ myl446/BRWHNHA. MicroRNAs (miRNAs) are a class of short non-coding RNAs (21-25 nt) 1-3 . As an important transcriptional regulatory factor, miRNAs are widely involved in the biological procedures of disease-related gene regulation, which is closely related to human multi-gene diseases 4-7 . Increasing evidences have demonstrated that miRNAs play a critical role in the emergence and development of diseases 8, 9 . Hence, revealing miRNAs associated diseases is an efficient way to accelerate the acquaintance about disease pathology at the molecular level 10-13 .
Results
To evaluate the prediction effectiveness of BRWHNHA in exploring undiscovered association between miRNAs and diseases, we compared BRWHNHA with MIDPE 17 , HAMDA 21 , and BRWH 22 by five-fold cross-validation with repeating 100 times on the dataset obtained by Luo and Xiao 22 . For a given disease, we randomly divided the known-related miRNAs into five subsets with equal size. For each round, we used one subset as testing set and other four subsets as training set. After 5 rounds, we calculated the average AUC value. In order to reduce false positive, we recalculated miRNAs similarity and obtained a bran-new similarity matrix in each round of prediction. Then we calculated the probability of association between the given disease and miRNAs by BRWHNHA. Finally, all candidate miRNAs were ranked by association probability. The higher the miRNAs in testing set were ranked, the better the performance. As the most of diseases only have a few association with miRNAs that have been proved, the performance of the prediction methods can not be accurately evaluated. Hence we only tested the 22 diseases associated with at least 60 miRNAs as Luo and Xiao 22 . We only showed recall-precision curve of breast neoplasms and lung neoplasms. In addition, we analyzed effect of parameters on performance of BRWHNHA.
performance evaluation. In this study, the novelty of BRWHNHA was to calculate the transition probability matrix of bipartite network by using hybrid recommendation algorithm, and then a bi-random walk on heterogeneous network based on hybrid approach was adopted. The average AUC is 83.55% without using hybrid recommendation algorithm, which was 2.14% less than using hybrid recommendation algorithm. Therefore, it is important to construct the transition probability matrix by hybrid recommendation algorithm. The prediction accuracy was actually improved by exploring the prior information and topological structure of bipartite networks. The same heterogeneous network was used on MIDPE 17 , HAMDA 21 and BRWH 22 . The best parameters of α = 0.9 and γ = 0.8 for MIDPE, σ = 0.7 and ρ = 0.8 for HAMDA λ = 0.6, α = 0.4, r = 2, l = 1 for BRWH were adopted as reported in original papers.
As illustrated in Table 1 , the average AUC values of MIDPE, HAMDA, BRWHA and BRWHNHA in 22 diseases are 83.55%, 85.00%, 83.49% and 85.69% respectively. BRWHNHA performed the best with AUC 2.13%, 0.69% and 2.20% higher than other three methods. Moreover, BRWHNHA is superior to MIDPE and BRWH in all measurements for 22 diseases. Although HAMDA achieves higher AUC than BRWHNHA in 7 out of 22 diseases, but BRWHNHA obtains better performance in most of diseases. Since HAMDA repeatedly uses the known miRNAs-disease association data in the measurement of miRNAs similarity, it maybe overestimate the results.
ROC curves of BRWHNHA and other three methods corresponding to the maximum AUC value in five-fold cross-validation at 100 times have shown in Supplementary Fig. S1 in Additional file.
In Fig. 1 , we compared BRWHNHA with other three methods in the recall-precision curves of breast neoplasms and lung neoplasms based on five-fold cross-validation. The precision-recall curve was obtained by measuring recall and precision at positions of top k (k = 10, 20, …, 100). The results show that our method achieves the highest precision and recall in the top 20. Moreover, with the increase of k value, the precision of BRWHNHA decreases, but the recall increases. It suggestes that the associations ranked in top position have higher probability of being potential miRNA-disease associations. We also compared the statistical significance of the difference in predictive ability between BRWHNHA and other three methods by paired t-tests. The P-values are listed in Table 2 . Obviously, BRWHNHA achieves better performance than MIDPE, HAMDA, BRWHA at the significance level of 0.05. We also compared our method with SPM on the dataset used by Zeng et al. 23 . We found that our method performs slightly better than SPM on five subsets with equal size in five-fold cross-validation in most cases (comparison results are not shown here).
Effect of parameters in BRWHNHA.
There are four parameters λ, α, r and l explored in our method. The parameter λ is the hybridization parameter to mediate between HeatS algorithm and ProbS algorithm different kinds of resource distribution processes, and parameter α plays the role to control the consistence between the predicted candidate miRNA-disease associations and the known associations. The parameters of r and l are the numbers of maximal random walk steps in miRNA similarity network and disease similarity network, respectively. We set various values of λ and α ranging from 0 to 1, the step length was 0.1. r and l were taken to be between 0 step to 5 steps, the step length was 1. Then, we calculated average AUC in the framework of five-fold cross-validation. Table 3 shows the effects of λ, α, r and l on the cross validation result in miRNA-disease association dataset. It can be observed that BRWHNHA achieves the best performance, when λ = 0.6, α = 0.4, r = 2, l = 1.
Case study
To further validate efficiency of BRWHNHA for discovering the potential associations between miRNAs and diseases, we conducted two case studies of Lung neoplasms and Prostatic neoplasms here. All known miRNA-disease associations released in June 2014 were regarded as training sets, and the set of candidate associations formed by all other associations. The prediction results of Lung neoplasms and Prostatic neoplasms were confirmed based on relevant literatures and two important public database: dbDEMC 24 and MiR2Disease 25 .
Lung cancer is one of the malignant tumors with the highest morbidity and mortality, and it is the greatest health and life threat to human. Over the past 50 years, many countries have reported significant increases in the incidence and mortality of lung cancer. The first 50 predicted miRNA associated with lung cancer were shown in Table 4 . As a result, among the top 20 and 50 potential Lung neoplasms associated miRNAs, 20 and 49 were confirmed by dbDEMC database, MiR2Disease and literature. Though there is no database or literature that proved the miRNA (hsa-mir-200) relevance to lung neoplasms, the mir-200 family, which includes 5 members (miRNA-200a, miRNA-200b, miRNA-200c, miRNA-429, and miRNA-141), is associated with Lung neoplasms in dbDEMC, so we have reason to believe that it is related to the disease. In addition, we also listed the potential miRNAs from top 51 to top100 ( Supplementary Table S2 in Additional file 1). www.nature.com/scientificreports www.nature.com/scientificreports/ Prostate neoplasms is an important malignant tumor in male patients. There are usually no clinical symptoms in the early stage. Currently, most of the patients admitted by prostate neoplasms are in the late stage 26 . Therefore, early diagnosis is an urgent problem. There are many evidences that have confirmed a link between miRNA and prostate neoplasms, and it could be therapeutically useful for the treatment of prostate neoplasms by regulating the expression of related miRNAs 27, 28 . As a result of the case study for prostate neoplasms, 18 out of the top-20 and 46 out of the top-50 predicted miRNAs of prostate neoplasms were verified by dbDEMC, MiR2Disease and literature (shown in Table 5 ). However, hsa-mir-302f, hsa-mir-1915, hsa-mir-4257 and hsa-mir-1286 are not included in dbDEMC, MiR2Disease and literature. We also listed the potential miRNAs from top 51 to top100 ( Supplementary Table S3 in Additional file 1).
Conclusion
Taking full account of the different topological and structural characteristics of heterogeneous network is a very challenging and meaningful task in prioritizing potential disease-related miRNAs. In this paper, we first adopted an effective measurement, which is suitable for miRNAs and diseases without known miRNA-disease associations, to estimate the similarity of miRNAs and diseases. Then, we presented a BRWHNHA method based on hybrid recommendation algorithm and unbalanced bi-random walk to predict potential diseases associated miRNAs. We made full use of the prior information and topological structural by calculating the transition probability matrix of bipartite network in using hybrid recommendation algorithm, in addition, we fully exploited the topologies and structures of miRNA similarity network(MMS) and disease similarity network(DDS) in the different lever by adopting unbalanced bi-random walk on heterogeneous network. To assess the performance of BRWHNHA, we compared BRWHNHA with MIDP, HAMDA and BRWH on the dataset obtained by Luo and Xiao 22 . The results indicate that BRWHNHA has the best prediction ability among these methods, the average AUC was 2.13%, 0.69% and 2.20% higher than MIDP, HAMDA and BRWH, respectively. Furthermore, case studies on lung neoplasms and prostatic were employed to further identify the performance evaluation of BRWHNHA, which the top 49 out of 50 and 46 out of 50 predicted miRNA-disease associations respectively were confirmed by recently published literature and databases of dbDEMC and MiR2Disease. The results show that BRWHNHA can be used as an effective and important method to explore the potential association between miRNAs and diseases.
Nevertheless, there is a limitation on our BRWHNHA that should be improved in future study. That is there are many parameters need to be set in this method. So a more effective method need be adopted to find the optimal parameters. www.nature.com/scientificreports www.nature.com/scientificreports/ Methods the measurement of disease semantic similarity and miRNA functional similarity. As described in the category C of MeSH descriptor, the disease relationships can be regarded as a directed acyclic graph structure. The disease K can be represented as DAG(K) = (K, T(K), E(K)) 22 , where T(K) represents the set of all the ancestor nodes of disease K and disease K, E(K) represents the set of all direct edges from parent nodes to child nodes in the subgraph, as shown in Fig. 2 . For two diseases d i and d j , the disease semantic similarity measurement DSS(d i , d j ) is defined by Luo and Xiao 22 .
Based on the assumption that miRNAs with similar functions are more likely to be associated with similar diseases and vice versa 29, 30 , the miRNA function similarity measurement MFS(m i , m j ) for two miRNAs m i and m j is adopted, which proposed by Wang et al. 31 .
Gaussian interaction profile kernel similarity. The Gaussian interaction profile kernel similarity also is based on the assumption that miRNAs with similar functions are more likely to be associated with similar diseases and vice versa. Let = × A a ( ) ij n n m d be the adjacency matrix of MD, and n m denotes the number of miRNAs and n d the number of diseases, respectively. The Gaussian interaction profile kernel similarity is calculated by the known miRNA-disease associations 21 , so let IP(d i ) binary vector indicate whether disease d i is associated with each miRNA, in other words, IP(d i ) is the ith column of A. The Gaussian interaction profile kernel similarity between two diseases d i and d j is calculated as: www.nature.com/scientificreports www.nature.com/scientificreports/ kernel similarity, as well as miRNA pair is estimated via integrating miRNA function similarity and miRNA Gaussian interaction profile kernel similarity. Then, the bipartite miRNA-disease network (MD) is constructed, where edges in the miRNA-disease network are the known associations between miRNAs and diseases that were released by HMDD in June 2014. The transition probability matrix of MD is obtained by using hybrid recommendation algorithm in bipartite networks. Then, unbalance bi-random walk is carried out in heterogeneous network that includes DDS, MMS and MD. Finally, for a given disease, all candidate miRNAs will be ranked according to transition probability matrix, and the higher the rank, the more likely it is to be associated with the given disease. Flowchart of potential miRNA-disease association prediction based on the computational model of BRWHNHA is shown in Fig. 4 . The most important 2 steps is:
Step Based on hybrid recommendation algorithm, the miRNA node m i is assigned an initial lever of resource f(m i ) = 1, or 0 depending on whether the miRNA is associated with given disease. All the resource of miRNA nodes redistributed via the transition matrix of hybrid recommendation algorithm, and transition probability matrix of MD is calculated as:
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Step 2 (Implement unbalance bi-random walk in heterogeneous network): Because of the different topological characteristics between MMS and DDS, in these two networks, we introduce two parameters of l and r as the biggest step random walk on MMS and DDS. α denotes a decay factor ranging from 0 and 1. The matrix P A is used to control the prior probability of the iterative process and is the transition probability matrix of the bipartite network G obtained by the recommendation algorithm. P A is a transition probability matrix, and P 0 = P A /sum(P A ). After several iterations, P t is the steady-state probability matrix between miRNAs and diseases. For a given disease, we ranked all the candidate miRNAs based on the probability. In BRWHNHA algorithm, we effectively utilize the topological information of heterogeneous networks, including: MMS, DDS and MD. 
